Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUGAR-DIP trial
NL-OMON47522Phase 3Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of metformin, glibenclamide and human insulin in gestational diabetes mellitus (GDM) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Large-for-gestational-age infant. Started Dec 2016; status: completed.
02
Drugs
metforminglibenclamidehuman insulin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NL-OMON47522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47522.